Skip to content
Assyro AI
510(k) Predicate Database
FDA 510(k) ClearanceGEX

Laser Fiber (PT-OF-A-S); Laser Fiber (PT-OF-B-S); Laser Fiber (PT-OF-C-S); Laser Fiber (PT-OF-D-S); Laser Fiber (PT-OF-E-S); Laser Fiber (PT-OF-F-S)

FDA 510(k) K253007 · Guangzhou Potent Medical Equipment Joint-Stock Co., Ltd.

510(k) number
K253007
Device name
Laser Fiber (PT-OF-A-S); Laser Fiber (PT-OF-B-S); Laser Fiber (PT-OF-C-S); Laser Fiber (PT-OF-D-S); Laser Fiber (PT-OF-E-S); Laser Fiber (PT-OF-F-S)
Applicant
Guangzhou Potent Medical Equipment Joint-Stock Co., Ltd.
Product code
GEX
Decision
Substantially Equivalent
Decision date
Device class
Class 2
Regulation number
878.4810
Advisory committee
SU
Medical specialty
General, Plastic Surgery

Candidate predicate devices

Other devices cleared under product code GEX form a screening cohort, not a predicate determination. Compare intended use, technological characteristics, performance evidence, labeling, and current legal-marketing status before selecting a predicate.

Candidate predicate devices for K253007
510(k)DeviceApplicantDecision date
K261221SOLTIVE™ Laser System (SOLTIVE™ Pro SuperPulsed Laser, SOLTIVE™ Premium SuperPulsed Laser, SOLTIVE Laser Fibers, and Accessories)Olympus Surgical Technologies America
K261738Medical Thulium Fiber Laser Systems (UroFiber 150Q)Rhein Laser Technologies Co., Ltd.
K261693Diode laser hair removal machine (QDTM-04)Beijing Nubway S&T Co., Ltd.
K261674Skin Air Cooling System (QALF-01)Beijing Nubway S&T Co., Ltd.
K261701Hemolase Fiber (Hemo-R-0.40-2.5/Hemo-R-0.60-2.5/Hemo-R-0.40-1.8/Hemo-R-0.60-1.8)Micro-Energy Medical Technology Co., Ltd.
K261570PICOSURE WORKSTATIONCynosure, LLC
K260690LumiGlam Laser System (SHE-LSP601-3)Beijing Sano Laser S&T Development Co.,Ltd
K260138LUNE PureHygieneEnamel Pure
K260489LASEmaR 1500Eufoton S.R.L.
K253245Boston 2910 (Boston 2910)Boston Aesthetics, Inc.
K260100MOSES Raydar™Boston Scientific Corporation
K261214PICO SHINING (PICO-K; PICOFY)Speclipse, Inc.

Building a 510(k) around this device type?

Assyro turns predicate research into a substantial-equivalence comparison and an eSTAR-ready 510(k) workflow — so predicate strategy, testing evidence, and labeling stay aligned before FDA review.